Newfound Research’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-489
| Closed | -$128K | – | 152 |
|
|
2022
Q1 | $128K | Sell |
489
-201
| -29% | -$52.6K | 0.17% | 70 |
|
|
2021
Q4 | $152K | Buy |
690
+113
| +20% | +$24.9K | 0.18% | 48 |
|
|
2021
Q3 | $105K | Buy |
577
+188
| +48% | +$34.2K | 0.17% | 62 |
|
|
2021
Q2 | $78K | Buy |
389
+37
| +11% | +$7.42K | 0.15% | 84 |
|
|
2021
Q1 | $76K | Buy |
352
+172
| +96% | +$37.1K | 0.18% | 62 |
|
|
2020
Q4 | $43K | Buy |
180
+75
| +71% | +$17.9K | 0.11% | 119 |
|
|
2020
Q3 | $29K | Buy |
+105
| New | +$29K | 0.08% | 91 |
|